1. Home
  2. KC vs ZLAB Comparison

KC vs ZLAB Comparison

Compare KC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KC
  • ZLAB
  • Stock Information
  • Founded
  • KC 2012
  • ZLAB 2013
  • Country
  • KC China
  • ZLAB China
  • Employees
  • KC N/A
  • ZLAB N/A
  • Industry
  • KC Computer Software: Prepackaged Software
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • KC Technology
  • ZLAB Health Care
  • Exchange
  • KC Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • KC 3.2B
  • ZLAB 3.6B
  • IPO Year
  • KC 2020
  • ZLAB 2017
  • Fundamental
  • Price
  • KC $12.02
  • ZLAB $36.40
  • Analyst Decision
  • KC Strong Buy
  • ZLAB Buy
  • Analyst Count
  • KC 4
  • ZLAB 5
  • Target Price
  • KC $9.10
  • ZLAB $54.28
  • AVG Volume (30 Days)
  • KC 1.9M
  • ZLAB 886.5K
  • Earning Date
  • KC 08-19-2025
  • ZLAB 08-05-2025
  • Dividend Yield
  • KC N/A
  • ZLAB N/A
  • EPS Growth
  • KC N/A
  • ZLAB N/A
  • EPS
  • KC N/A
  • ZLAB N/A
  • Revenue
  • KC $1,099,631,090.00
  • ZLAB $418,326,000.00
  • Revenue This Year
  • KC $22.58
  • ZLAB $44.07
  • Revenue Next Year
  • KC $15.73
  • ZLAB $49.13
  • P/E Ratio
  • KC N/A
  • ZLAB N/A
  • Revenue Growth
  • KC 14.67
  • ZLAB 43.72
  • 52 Week Low
  • KC $2.02
  • ZLAB $16.01
  • 52 Week High
  • KC $22.26
  • ZLAB $44.34
  • Technical
  • Relative Strength Index (RSI)
  • KC 45.43
  • ZLAB 52.67
  • Support Level
  • KC $11.68
  • ZLAB $34.79
  • Resistance Level
  • KC $12.57
  • ZLAB $36.73
  • Average True Range (ATR)
  • KC 0.45
  • ZLAB 1.23
  • MACD
  • KC 0.00
  • ZLAB -0.46
  • Stochastic Oscillator
  • KC 26.96
  • ZLAB 25.91

About KC Kingsoft Cloud Holdings Limited

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: